IQVIA Holdings Inc. (IQV)
USD 153.48
(1.58%)
USD 153.48
(1.58%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 12.95 Billion USD | 0.75% |
| 2022 | 12.85 Billion USD | 4.15% |
| 2021 | 12.34 Billion USD | -3.2% |
| 2020 | 12.75 Billion USD | 6.82% |
| 2019 | 11.94 Billion USD | 9.48% |
| 2018 | 10.9 Billion USD | 7.76% |
| 2017 | 10.12 Billion USD | 42.4% |
| 2016 | 7.1 Billion USD | 193.8% |
| 2015 | 2.41 Billion USD | 5.53% |
| 2014 | 2.29 Billion USD | 12.62% |
| 2013 | 2.03 Billion USD | -13.97% |
| 2012 | 2.36 Billion USD | 21.24% |
| 2011 | 1.95 Billion USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q3 | 12.29 Billion USD | 1.67% |
| 2024 Q2 | 12.09 Billion USD | -5.68% |
| 2024 Q1 | 12.81 Billion USD | -1.05% |
| 2023 Q2 | 12.67 Billion USD | 4.86% |
| 2023 Q3 | 12.53 Billion USD | -1.07% |
| 2023 Q4 | 12.95 Billion USD | 3.32% |
| 2023 FY | 12.95 Billion USD | 0.75% |
| 2023 Q1 | 12.08 Billion USD | -6.0% |
| 2022 Q1 | 12.85 Billion USD | 4.13% |
| 2022 FY | 12.85 Billion USD | 4.15% |
| 2022 Q2 | 12.9 Billion USD | 0.33% |
| 2022 Q4 | 12.85 Billion USD | 2.86% |
| 2022 Q3 | 12.5 Billion USD | -3.09% |
| 2021 Q3 | 12.4 Billion USD | -0.65% |
| 2021 Q2 | 12.48 Billion USD | 0.37% |
| 2021 Q1 | 12.43 Billion USD | -2.48% |
| 2021 FY | 12.34 Billion USD | -3.2% |
| 2021 Q4 | 12.34 Billion USD | -0.46% |
| 2020 Q4 | 12.75 Billion USD | 1.37% |
| 2020 FY | 12.75 Billion USD | 6.82% |
| 2020 Q1 | 12.26 Billion USD | 2.67% |
| 2020 Q2 | 12.36 Billion USD | 0.87% |
| 2020 Q3 | 12.58 Billion USD | 1.74% |
| 2019 Q2 | 11.69 Billion USD | 0.94% |
| 2019 Q3 | 11.83 Billion USD | 1.2% |
| 2019 Q1 | 11.58 Billion USD | 6.24% |
| 2019 FY | 11.94 Billion USD | 9.48% |
| 2019 Q4 | 11.94 Billion USD | 0.88% |
| 2018 Q2 | 10.62 Billion USD | 2.76% |
| 2018 FY | 10.9 Billion USD | 7.76% |
| 2018 Q4 | 10.9 Billion USD | 3.7% |
| 2018 Q3 | 10.51 Billion USD | -1.03% |
| 2018 Q1 | 10.34 Billion USD | 2.17% |
| 2017 Q1 | 8.25 Billion USD | 16.12% |
| 2017 FY | 10.12 Billion USD | 42.4% |
| 2017 Q4 | 10.12 Billion USD | 4.88% |
| 2017 Q3 | 9.65 Billion USD | 8.95% |
| 2017 Q2 | 8.85 Billion USD | 7.32% |
| 2016 FY | 7.1 Billion USD | 193.8% |
| 2016 Q4 | 7.1 Billion USD | 197.77% |
| 2016 Q3 | 2.38 Billion USD | -0.45% |
| 2016 Q2 | 2.39 Billion USD | -0.45% |
| 2016 Q1 | 2.4 Billion USD | -0.44% |
| 2015 Q3 | 2.43 Billion USD | -0.45% |
| 2015 Q2 | 2.44 Billion USD | 6.68% |
| 2015 Q1 | 2.28 Billion USD | -0.19% |
| 2015 FY | 2.41 Billion USD | 5.53% |
| 2015 Q4 | 2.41 Billion USD | -0.44% |
| 2014 Q2 | 2.02 Billion USD | -0.21% |
| 2014 Q3 | 2.02 Billion USD | -0.21% |
| 2014 Q1 | 2.03 Billion USD | -0.21% |
| 2014 FY | 2.29 Billion USD | 12.62% |
| 2014 Q4 | 2.29 Billion USD | 13.34% |
| 2013 Q3 | 2.04 Billion USD | -0.15% |
| 2013 FY | 2.03 Billion USD | -13.97% |
| 2013 Q2 | 2.04 Billion USD | -13.15% |
| 2013 Q1 | 2.35 Billion USD | -0.49% |
| 2013 Q4 | 2.03 Billion USD | -0.32% |
| 2012 FY | 2.36 Billion USD | 21.24% |
| 2012 Q4 | 2.36 Billion USD | 0.0% |
| 2011 FY | 1.95 Billion USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Agilent Technologies, Inc. | 2.73 Billion USD | -373.675% |
| Charles River Laboratories International, Inc. | 3.06 Billion USD | -322.485% |
| Quest Diagnostics Incorporated | 4.41 Billion USD | -193.764% |
| Danaher Corporation | 17.66 Billion USD | 26.646% |
| Enzo Biochem, Inc. | 189 Thousand USD | -6854397.354% |
| Laboratory Corporation of America Holdings | 4.05 Billion USD | -219.506% |
| Mettler-Toledo International Inc. | 1.88 Billion USD | -585.951% |
| Qiagen N.V. | 921.82 Million USD | -1305.366% |
| Revvity, Inc. | 3.17 Billion USD | -307.676% |
| Thermo Fisher Scientific Inc. | 31.3 Billion USD | 58.621% |
| Waters Corporation | 2.3 Billion USD | -461.914% |